Genesis Healthcare, Inc.
GENN · OTC
12/31/2020 | 12/31/2019 | 12/31/2018 | 12/31/2017 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.00 | -0.11 | 0.01 | -0.00 |
| FCF Yield | 479.79% | -39.72% | -27.32% | 78.40% |
| EV / EBITDA | 20.21 | 14.51 | 16.17 | -23.57 |
| Quality | ||||
| ROIC | 19.34% | 29.81% | 6.00% | 4.61% |
| Gross Margin | 42.24% | 45.57% | 44.00% | 43.49% |
| Cash Conversion Ratio | -3.05 | -0.96 | -0.05 | -0.13 |
| Growth | ||||
| Revenue 3-Year CAGR | -7.76% | -5.29% | -4.60% | -1.48% |
| Free Cash Flow Growth | 472.16% | -114.61% | -157.80% | 327.61% |
| Safety | ||||
| Net Debt / EBITDA | 19.91 | 13.96 | 15.78 | -23.23 |
| Interest Coverage | 7.79 | 8.24 | 0.45 | 0.37 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 5.70 | 10.36 | 14.92 | 14.85 |